O	O	0	13	Transcription	Transcription	B-NP	NN	B-protein	2	NMOD	B-protein
O	O	14	21	factors	factor	I-NP	NNS	I-protein	0	ROOT	I-protein
O	O	22	24	in	in	B-PP	IN	O	2	NMOD	O
O	O	25	31	immune	immune	B-NP	JJ	O	6	AMOD	O
O	O	31	32	-	-	I-NP	HYPH	O	6	P	O
O	O	32	40	mediated	mediate	I-NP	VBN	O	7	NMOD	O
O	O	41	48	disease	disease	I-NP	NN	O	3	PMOD	O
O	O	48	49	.	.	O	.	O	2	P	O

O	O	51	52	A	A	B-NP	DT	O	3	NMOD	O
O	O	53	58	large	large	I-NP	JJ	O	3	NMOD	O
O	O	59	65	amount	amount	I-NP	NN	O	27	SUB	O
O	O	66	68	of	of	B-PP	IN	O	3	NMOD	O
O	O	69	77	detailed	detailed	B-NP	JJ	O	6	NMOD	O
O	O	78	89	information	information	I-NP	NN	O	4	PMOD	O
O	O	90	95	about	about	B-PP	IN	O	3	NMOD	O
O	O	96	99	the	the	B-NP	DT	O	10	NMOD	O
O	O	100	113	intracellular	intracellular	I-NP	JJ	B-protein	10	NMOD	B-protein
O	O	114	122	proteins	protein	I-NP	NNS	I-protein	7	PMOD	I-protein
O	O	123	133	regulating	regulate	B-VP	VBG	O	10	NMOD	O
T4	B-Entity	134	136	NF	NF	B-NP	NN	B-protein	15	NMOD	B-protein
T4	I-Entity	136	137	-	-	B-NP	HYPH	I-protein	15	NMOD	I-protein
T4	I-Entity	137	142	kappa	kappa	I-NP	NN	I-protein	15	NMOD	I-protein
T4	I-Entity	143	144	B	B	I-NP	NN	I-protein	16	NMOD	I-protein
O	O	145	155	activation	activation	I-NP	NN	O	20	NMOD	O
O	O	156	159	and	and	O	CC	O	20	NMOD	O
O	O	160	163	the	the	B-NP	DT	O	20	NMOD	O
O	O	164	172	cellular	cellular	I-NP	JJ	O	20	NMOD	O
O	O	173	181	response	response	I-NP	NN	O	11	OBJ	O
O	O	182	184	to	to	B-PP	TO	O	20	NMOD	O
T5	B-Entity	185	187	NF	NF	B-NP	NN	B-protein	26	NMOD	B-protein
T5	I-Entity	187	188	-	-	B-NP	HYPH	I-protein	26	NMOD	I-protein
T5	I-Entity	188	193	kappa	kappa	I-NP	NN	I-protein	26	NMOD	I-protein
T5	I-Entity	194	195	B	B	I-NP	NN	I-protein	26	NMOD	I-protein
O	O	196	206	activation	activation	I-NP	NN	O	21	PMOD	O
O	O	207	210	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	211	218	emerged	emerge	I-VP	VBN	O	27	VC	O
O	O	219	227	recently	recently	B-ADVP	RB	O	28	VMOD	O
O	O	227	228	.	.	O	.	O	27	P	O

O	O	229	236	Several	Several	B-NP	JJ	O	3	NMOD	O
O	O	237	242	small	small	I-NP	JJ	O	3	NMOD	O
O	O	243	252	molecules	molecule	I-NP	NNS	O	12	NMOD	O
O	O	252	253	,	,	O	,	O	12	P	O
O	O	254	256	an	an	B-NP	DT	O	7	NMOD	O
T6	B-Entity	257	266	antisense	antisense	I-NP	JJ	O	7	NMOD	O
T6	I-Entity	267	282	oligonucleotide	oligonucleotide	I-NP	NN	O	12	NMOD	O
O	O	282	283	,	,	O	,	O	12	P	O
O	O	284	287	and	and	O	CC	O	12	NMOD	O
O	O	288	292	gene	gene	B-NP	NN	O	12	NMOD	O
O	O	293	304	therapeutic	therapeutic	I-NP	JJ	O	12	NMOD	O
O	O	305	311	agents	agent	I-NP	NNS	O	20	SUB	O
O	O	312	316	that	that	B-NP	WDT	O	12	NMOD	O
O	O	317	324	inhibit	inhibit	B-VP	VBP	O	13	SBAR	O
T7	B-Entity	325	327	NF	NF	B-NP	NN	B-protein	18	NMOD	B-protein
T7	I-Entity	327	328	-	-	B-NP	HYPH	I-protein	18	NMOD	I-protein
T7	I-Entity	328	333	kappa	kappa	I-NP	NN	I-protein	18	NMOD	I-protein
T7	I-Entity	334	335	b	b	I-NP	NN	I-protein	19	NMOD	I-protein
O	O	336	346	activation	activation	I-NP	NN	O	14	OBJ	O
O	O	347	351	have	have	B-VP	VBP	O	0	ROOT	O
O	O	352	356	been	be	I-VP	VBN	O	20	VC	O
O	O	357	366	described	describe	I-VP	VBN	O	21	VC	O
O	O	366	367	.	.	O	.	O	20	P	O

O	O	368	375	Despite	Despite	B-PP	IN	O	5	VMOD	O
O	O	376	380	this	this	B-NP	DT	O	1	PMOD	O
O	O	380	381	,	,	O	,	O	5	P	O
O	O	382	387	there	there	B-NP	EX	O	5	SUB	O
O	O	388	391	are	be	B-VP	VBP	O	0	ROOT	O
O	O	392	397	still	still	B-ADVP	RB	O	5	VMOD	O
O	O	398	409	significant	significant	B-NP	JJ	O	8	NMOD	O
O	O	410	414	gaps	gap	I-NP	NNS	O	5	PRD	O
O	O	415	417	in	in	B-PP	IN	O	5	VMOD	O
O	O	418	421	our	our	B-NP	PRP$	O	11	NMOD	O
O	O	422	435	understanding	understanding	I-NP	NN	O	9	PMOD	O
O	O	436	438	of	of	B-PP	IN	O	11	NMOD	O
O	O	439	443	this	this	B-NP	DT	O	14	NMOD	O
O	O	444	451	process	process	I-NP	NN	O	17	NMOD	O
O	O	452	455	and	and	O	CC	O	17	NMOD	O
O	O	456	459	its	its	B-NP	PRP$	O	17	NMOD	O
O	O	460	472	consequences	consequence	I-NP	NNS	O	12	PMOD	O
O	O	472	473	.	.	O	.	O	5	P	O

O	O	474	476	In	In	B-PP	IN	O	19	VMOD	O
O	O	477	485	contrast	contrast	B-NP	NN	O	1	PMOD	O
O	O	485	486	,	,	O	,	O	19	P	O
O	O	487	490	the	the	B-NP	DT	O	5	NMOD	O
O	O	491	507	characterization	characterization	I-NP	NN	O	19	SUB	O
O	O	508	510	of	of	B-PP	IN	O	5	NMOD	O
O	O	511	524	transcription	transcription	B-NP	NN	B-protein	8	NMOD	B-protein
O	O	525	532	factors	factor	I-NP	NNS	I-protein	6	PMOD	I-protein
O	O	533	544	selectively	selectively	B-VP	RB	O	10	VMOD	O
O	O	545	555	regulating	regulate	I-VP	VBG	O	8	NMOD	O
O	O	556	564	cytokine	cytokine	B-NP	NN	B-protein	12	NMOD	B-protein
O	O	565	575	production	production	I-NP	NN	O	10	OBJ	O
O	O	576	578	by	by	B-PP	IN	O	12	NMOD	O
T1	B-Protein	579	582	CD4	CD4	B-NP	NN	B-protein	18	NMOD	B-protein
O	O	582	583	+	+	O	SYM	O	18	NMOD	O
O	O	584	585	T	T	B-NP	NN	B-cell_type	18	NMOD	B-cell_type
O	O	586	590	cell	cell	I-NP	NN	I-cell_type	18	NMOD	I-cell_type
O	O	591	598	subsets	subset	I-NP	NNS	I-cell_type	13	PMOD	I-cell_type
O	O	599	601	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	602	604	at	at	B-PP	IN	O	19	PRD	O
O	O	605	606	a	a	B-NP	DT	O	24	NMOD	O
O	O	607	611	very	very	I-NP	RB	O	23	AMOD	O
O	O	612	617	early	early	I-NP	JJ	O	24	NMOD	O
O	O	618	623	stage	stage	I-NP	NN	O	20	PMOD	O
O	O	623	624	.	.	O	.	O	19	P	O

O	O	625	630	Three	Three	B-NP	CD	O	4	SUB	O
O	O	631	642	interacting	interact	I-NP	VBG	B-protein	3	NMOD	B-protein
O	O	643	651	proteins	protein	I-NP	NNS	I-protein	1	NMOD	I-protein
O	O	652	656	have	have	B-VP	VBP	O	0	ROOT	O
O	O	657	665	recently	recently	I-VP	RB	O	4	VMOD	O
O	O	666	670	been	be	I-VP	VBN	O	4	VC	O
O	O	671	676	shown	show	I-VP	VBN	O	6	VC	O
O	O	677	679	to	to	I-VP	TO	O	9	VMOD	O
O	O	680	690	contribute	contribute	I-VP	VB	O	7	VMOD	O
O	O	691	693	to	to	B-PP	TO	O	9	VMOD	O
O	O	694	700	subset	subset	B-NP	NN	O	14	NMOD	O
O	O	700	701	-	-	B-NP	HYPH	O	14	NMOD	O
O	O	701	711	restricted	restrict	I-NP	VBN	O	14	NMOD	O
O	O	712	722	expression	expression	I-NP	NN	O	10	PMOD	O
O	O	723	725	of	of	B-PP	IN	O	14	NMOD	O
O	O	726	729	the	the	B-NP	DT	O	20	NMOD	O
T2	B-Protein	730	732	IL	IL	I-NP	NN	B-DNA	20	NMOD	B-DNA
T2	I-Protein	732	733	-	-	B-NP	HYPH	I-DNA	20	NMOD	I-DNA
T2	I-Protein	733	734	4	4	I-NP	CD	I-DNA	20	NMOD	I-DNA
O	O	735	739	gene	gene	I-NP	NN	I-DNA	15	PMOD	I-DNA
O	O	739	740	.	.	O	.	O	4	P	O

O	O	741	746	There	There	B-NP	EX	O	2	SUB	O
O	O	747	750	are	be	B-VP	VBP	O	23	VMOD	O
O	O	751	756	other	other	B-NP	JJ	O	4	NMOD	O
O	O	757	765	elements	element	I-NP	NNS	O	2	PRD	O
O	O	766	776	regulating	regulate	B-VP	VBG	O	4	NMOD	O
T3	B-Protein	777	779	IL	IL	B-NP	NN	B-DNA	9	NMOD	B-DNA
T3	I-Protein	779	780	-	-	B-NP	HYPH	I-DNA	9	NMOD	I-DNA
T3	I-Protein	780	781	4	4	I-NP	CD	I-DNA	9	NMOD	I-DNA
O	O	782	786	gene	gene	I-NP	NN	I-DNA	10	NMOD	I-DNA
O	O	787	797	expression	expression	I-NP	NN	O	5	OBJ	O
O	O	797	798	,	,	O	,	O	23	P	O
O	O	799	806	however	however	B-ADVP	RB	O	23	VMOD	O
O	O	806	807	,	,	O	,	O	23	P	O
O	O	808	811	and	and	O	CC	O	23	VMOD	O
O	O	812	815	the	the	B-NP	DT	O	17	NMOD	O
O	O	816	824	relative	relative	I-NP	JJ	O	17	NMOD	O
O	O	825	835	importance	importance	I-NP	NN	O	23	SUB	O
O	O	836	838	of	of	B-PP	IN	O	17	NMOD	O
O	O	839	844	these	these	B-NP	DT	O	22	NMOD	O
O	O	845	853	recently	recently	I-NP	RB	O	21	AMOD	O
O	O	854	864	identified	identify	I-NP	VBN	O	22	NMOD	O
O	O	865	873	proteins	protein	I-NP	NNS	O	18	PMOD	O
O	O	874	877	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	878	881	yet	yet	I-VP	RB	O	26	VMOD	O
O	O	882	884	to	to	I-VP	TO	O	26	VMOD	O
O	O	885	887	be	be	I-VP	VB	O	23	VMOD	O
O	O	888	898	determined	determine	I-VP	VBN	O	26	VC	O
O	O	898	899	.	.	O	.	O	23	P	O
